NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (F: NOVC)

 
NOVC Technical Analysis
5
As on 13th Sep 2023 NOVC STOCK Price closed @ 90.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 112.41 & Strong Sell for SHORT-TERM with Stoploss of 104.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVCSTOCK Price

Open 91.54 Change Price %
High 91.54 1 Day -1.40 -1.52
Low 88.76 1 Week -87.14 -49.00
Close 90.70 1 Month -53.86 -37.26
Volume 2800 1 Year -17.36 -16.07
52 Week High 183.22 | 52 Week Low 92.85
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
NT5 1000000.00 4629529.50%
NT5 1000000.00 4629529.50%
NT5 1000000.00 4629529.50%
30T 1000000.00 3759298.50%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
LDB 1.71 -92.57%
 
 
NOVC
Daily Charts
NOVC
Intraday Charts
Whats New @
Bazaartrend
NOVC
Free Analysis
 
NOVC Important Levels Intraday
RESISTANCE96.06
RESISTANCE94.34
RESISTANCE93.28
RESISTANCE92.22
SUPPORT89.18
SUPPORT88.12
SUPPORT87.06
SUPPORT85.34
 
NOVC Forecast February 2026
4th UP Forecast111.78
3rd UP Forecast105.02
2nd UP Forecast100.84
1st UP Forecast96.66
1st DOWN Forecast84.74
2nd DOWN Forecast80.56
3rd DOWN Forecast76.38
4th DOWN Forecast69.62
 
NOVC Weekly Forecast
4th UP Forecast109.58
3rd UP Forecast103.53
2nd UP Forecast99.78
1st UP Forecast96.04
1st DOWN Forecast85.36
2nd DOWN Forecast81.62
3rd DOWN Forecast77.87
4th DOWN Forecast71.82
 
NOVC Forecast2026
4th UP Forecast276.54
3rd UP Forecast216.94
2nd UP Forecast180.1
1st UP Forecast143.26
1st DOWN Forecast38.14
2nd DOWN Forecast1.3
3rd DOWN Forecast-35.54
4th DOWN Forecast-95.14
 
 
NOVC Other Details
Segment EQ
Market Capital 207942189056.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVC Address
NOVC
 
NOVC Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVC Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service